Filter
830
Text search:
adverse
drug
reactions
Featured
116
225
Language
Document type
485
164
83
53
14
12
10
4
3
1
1
Countries
68
26
24
23
21
20
20
18
16
16
13
10
10
10
10
9
9
8
8
8
8
7
6
6
6
5
5
5
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
325
117
42
26
18
13
12
Toolboxes
122
79
66
51
34
34
27
17
17
16
14
8
8
7
6
5
4
4
3
3
3
3
3
1
Towards the Peoples Health Assembly Book -5
CHAPTER 15:03 | Acts 14/1969, 62/1971, 35/1974, 20/1978, 41/1978 (s. 35) 39/1979, 7/1987, 11/1988, 18/1989 (s. 27), 1/1996, 6/2000, 22/2001; R.G.N. 899/1978.
Blueprint for EECA countries, first edition
A Guide For Multicentre Trials in High-Burden Countries
Int J Vaccines Vaccin 2016, 2(1): 00018, January 29, 2016
4–15 February 2013
14–22 April 2015
Draft for consultation
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Introduction
Chapter A.7
Introduction
Chapter A.9
Mood disorders
Chapter E.2
Mood disorders
Chapter E.3
2016 edition
Substance use disorders
Chapter G.3
